Viewing Study NCT01567995


Ignite Creation Date: 2025-12-24 @ 1:33 PM
Ignite Modification Date: 2026-02-07 @ 9:12 PM
Study NCT ID: NCT01567995
Status: COMPLETED
Last Update Posted: 2017-11-28
First Post: 2012-03-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Eczema View
Keywords:

Keywords

Keyword Brief Keyword Text View
None eczematous View
None dermatitis View